A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.
Naval G DaverAmandeep SalhotraJoseph M BrandweinNikolai A PodoltsevDaniel A PollyeaJoseph G JurcicSarit AssoulineKaren YeeMengsong LiTony PourmohamadDivya SamineniTeiko SumiyoshiAnjali VazeRandall C DereConnie MaJames CooperPublished in: American journal of hematology (2021)